
    
      This study is an open-label, multi-site, stratified randomized, wait list control, pilot
      study. The study will be conducted at up to 2 sites in the United States and enroll 40
      subjects with a diagnosis of head and neck lymphedema following treatment for head and neck
      cancer. Subjects randomized to receive daily treatment with the Flexitouch pneumatic
      compression device and home care regimen (SOC) will be seen at baseline and weeks 1, 4, and
      8. Subjects randomized to the wait list arm will be seen at baseline and weeks 1, 4, and 8
      while receiving SOC treatment. Assessments will include fidelity, satisfaction, symptoms,
      swelling/inflammation, function, and QOL.
    
  